Molecular biology enzyme is the protein which is naturally produced by plant, animal & bacteria. These are biocatalysts used in molecular biology to optimize the workflow. Molecular kits, reagents and enzymes are being used across various applications in fields such as diagnosis, research & development and various life science research activities. In molecular biology, these products are used to analyze various biomarkers & cell surface markers that function as therapeutic/diagnostic targets.
Continuous technological advancements in the molecular biology field have significantly impacted the life sciences investigations carried out for the management of medical conditions, thereby driving the usage of molecular biology consumables. Also, the increase in research and development activities as well as investments in the science industry will positively influence the growth of global molecular biology enzymes and kits & reagents market over the forecast period.
Impact of COVID 19 on Market
The increase in spread of coronavirus (COVID-19) is expected to boost the growth of global molecular biology enzymes and kits & reagents market over the forecast period.
For instance, in march 2020, Roche has announced that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for the cobas SARS-CoV-2 Test. It is intended for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19 disease, in nasopharyngeal and oropharyngeal swab samples from patients who meet COVID-19 clinical and/or epidemiological criteria for testing.
Key players are listed in this report such as Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Promega Corporation, Illumina Inc., Qiagen, New England Biolabs, Takara Bio, Inc. Hoffmann-La Roche Ltd, Merck KGaA., etc.
North America Latin America Europe Asia Pacific Middle East & Africa
Regional Analysis
The Global Molecular Biology Enzymes and Kits & Reagents Market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America region is expected to account for the largest share of the market in 2020. Due to the increase in research funding for genomics research, growing number of pharmaceutical and biotechnology companies, increasing prevalence of conditions involving molecular diagnostics as well the rise in investments in research projects in Canada.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
